
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
STING inhibits the reactivation of dormant metastasis in lung adenocarcinoma
Jing Hu, Francisco J. Sánchez‐Rivera, Zhenghan Wang, et al.
Nature (2023) Vol. 616, Iss. 7958, pp. 806-813
Open Access | Times Cited: 126
Jing Hu, Francisco J. Sánchez‐Rivera, Zhenghan Wang, et al.
Nature (2023) Vol. 616, Iss. 7958, pp. 806-813
Open Access | Times Cited: 126
Showing 1-25 of 126 citing articles:
TGF-β signaling in health and disease
Joan Massagué, Dean Sheppard
Cell (2023) Vol. 186, Iss. 19, pp. 4007-4037
Open Access | Times Cited: 334
Joan Massagué, Dean Sheppard
Cell (2023) Vol. 186, Iss. 19, pp. 4007-4037
Open Access | Times Cited: 334
Non-cell-autonomous cancer progression from chromosomal instability
Jun Li, Melissa J. Hubisz, Ethan M. Earlie, et al.
Nature (2023) Vol. 620, Iss. 7976, pp. 1080-1088
Open Access | Times Cited: 131
Jun Li, Melissa J. Hubisz, Ethan M. Earlie, et al.
Nature (2023) Vol. 620, Iss. 7976, pp. 1080-1088
Open Access | Times Cited: 131
The hallmarks of cancer immune evasion
Claudia Galassi, Timothy A. Chan, Ilio Vitale, et al.
Cancer Cell (2024) Vol. 42, Iss. 11, pp. 1825-1863
Closed Access | Times Cited: 78
Claudia Galassi, Timothy A. Chan, Ilio Vitale, et al.
Cancer Cell (2024) Vol. 42, Iss. 11, pp. 1825-1863
Closed Access | Times Cited: 78
Harnessing innate immune pathways for therapeutic advancement in cancer
An-Kang Hu, Li Sun, Hao Lin, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 56
An-Kang Hu, Li Sun, Hao Lin, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 56
The two sides of chromosomal instability: drivers and brakes in cancer
Rendy Hosea, Sharon Hillary, S. Hassan R. Naqvi, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 45
Rendy Hosea, Sharon Hillary, S. Hassan R. Naqvi, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 45
Polymeric STING Pro‐agonists for Tumor‐Specific Sonodynamic Immunotherapy
Jie Yu, Shasha He, Chi Zhang, et al.
Angewandte Chemie International Edition (2023) Vol. 62, Iss. 32
Closed Access | Times Cited: 44
Jie Yu, Shasha He, Chi Zhang, et al.
Angewandte Chemie International Edition (2023) Vol. 62, Iss. 32
Closed Access | Times Cited: 44
Mechanism insights and therapeutic intervention of tumor metastasis: latest developments and perspectives
Xiaoli Shi, Xinyi Wang, Wentao Yao, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 39
Xiaoli Shi, Xinyi Wang, Wentao Yao, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 39
TREX1 Inactivation Unleashes Cancer Cell STING–Interferon Signaling and Promotes Antitumor Immunity
Tetsuo Tani, Haritha Mathsyaraja, Marco Campisi, et al.
Cancer Discovery (2024) Vol. 14, Iss. 5, pp. 752-765
Closed Access | Times Cited: 38
Tetsuo Tani, Haritha Mathsyaraja, Marco Campisi, et al.
Cancer Discovery (2024) Vol. 14, Iss. 5, pp. 752-765
Closed Access | Times Cited: 38
STING licensing of type I dendritic cells potentiates antitumor immunity
Jian Wang, Suxin Li, M. C. Wang, et al.
Science Immunology (2024) Vol. 9, Iss. 92
Open Access | Times Cited: 31
Jian Wang, Suxin Li, M. C. Wang, et al.
Science Immunology (2024) Vol. 9, Iss. 92
Open Access | Times Cited: 31
An Immunocompetent Hafnium Oxide-Based STING Nanoagonist for Cancer Radio-immunotherapy
Yuhua Cao, Shuaishuai Ding, Yunping Hu, et al.
ACS Nano (2024) Vol. 18, Iss. 5, pp. 4189-4204
Closed Access | Times Cited: 30
Yuhua Cao, Shuaishuai Ding, Yunping Hu, et al.
ACS Nano (2024) Vol. 18, Iss. 5, pp. 4189-4204
Closed Access | Times Cited: 30
LncRNA Malat1 suppresses pyroptosis and T cell-mediated killing of incipient metastatic cells
Dhiraj Kumar, Sreeharsha Gurrapu, Yan Wang, et al.
Nature Cancer (2024) Vol. 5, Iss. 2, pp. 262-282
Closed Access | Times Cited: 27
Dhiraj Kumar, Sreeharsha Gurrapu, Yan Wang, et al.
Nature Cancer (2024) Vol. 5, Iss. 2, pp. 262-282
Closed Access | Times Cited: 27
Cell-intrinsic and microenvironmental determinants of metastatic colonization
Arthur W. Lambert, Yun Zhang, Robert A. Weinberg
Nature Cell Biology (2024) Vol. 26, Iss. 5, pp. 687-697
Closed Access | Times Cited: 22
Arthur W. Lambert, Yun Zhang, Robert A. Weinberg
Nature Cell Biology (2024) Vol. 26, Iss. 5, pp. 687-697
Closed Access | Times Cited: 22
cGAS-STING pathway expression correlates with genomic instability and immune cell infiltration in breast cancer
Mengting Chen, Shibo Yu, Tineke van der Sluis, et al.
npj Breast Cancer (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 19
Mengting Chen, Shibo Yu, Tineke van der Sluis, et al.
npj Breast Cancer (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 19
Regulation of cGAS–STING signalling and its diversity of cellular outcomes
Zhengyin Zhang, Conggang Zhang
Nature reviews. Immunology (2025)
Closed Access | Times Cited: 6
Zhengyin Zhang, Conggang Zhang
Nature reviews. Immunology (2025)
Closed Access | Times Cited: 6
Inflammation in cancer: therapeutic opportunities from new insights
Yifei Xie, Fangfang Liu, Yunfei Wu, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Yifei Xie, Fangfang Liu, Yunfei Wu, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Traditional Chinese medicine in lung cancer treatment
Zhichao Xi, Rongchen Dai, Yufei Ze, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Zhichao Xi, Rongchen Dai, Yufei Ze, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Targeting STING in cancer: Challenges and emerging opportunities
Kexin Zhao, Jiaojiao Huang, Yue Zhao, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 6, pp. 188983-188983
Closed Access | Times Cited: 23
Kexin Zhao, Jiaojiao Huang, Yue Zhao, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 6, pp. 188983-188983
Closed Access | Times Cited: 23
Targeting cancer cell dormancy
Judith Agudo, Julio A. Aguirre‐Ghiso, Mickie Bhatia, et al.
Nature reviews. Cancer (2023) Vol. 24, Iss. 2, pp. 97-104
Open Access | Times Cited: 23
Judith Agudo, Julio A. Aguirre‐Ghiso, Mickie Bhatia, et al.
Nature reviews. Cancer (2023) Vol. 24, Iss. 2, pp. 97-104
Open Access | Times Cited: 23
Cancer drug-tolerant persister cells: from biological questions to clinical opportunities
Mariangela Russo, Mengnuo Chen, Elisa Mariella, et al.
Nature reviews. Cancer (2024) Vol. 24, Iss. 10, pp. 694-717
Closed Access | Times Cited: 15
Mariangela Russo, Mengnuo Chen, Elisa Mariella, et al.
Nature reviews. Cancer (2024) Vol. 24, Iss. 10, pp. 694-717
Closed Access | Times Cited: 15
Intratumoral TREX1 Induction Promotes Immune Evasion by Limiting Type I IFN
Eléonore Toufektchan, Alexandra Dananberg, Josefine Striepen, et al.
Cancer Immunology Research (2024) Vol. 12, Iss. 6, pp. 673-686
Open Access | Times Cited: 14
Eléonore Toufektchan, Alexandra Dananberg, Josefine Striepen, et al.
Cancer Immunology Research (2024) Vol. 12, Iss. 6, pp. 673-686
Open Access | Times Cited: 14
TGF-β and RAS jointly unmask primed enhancers to drive metastasis
Jun Ho Lee, Francisco J. Sánchez‐Rivera, Lan He, et al.
Cell (2024) Vol. 187, Iss. 22, pp. 6182-6199.e29
Closed Access | Times Cited: 12
Jun Ho Lee, Francisco J. Sánchez‐Rivera, Lan He, et al.
Cell (2024) Vol. 187, Iss. 22, pp. 6182-6199.e29
Closed Access | Times Cited: 12
Dormant cancer cells and polyploid giant cancer cells: The roots of cancer recurrence and metastasis
Yuqi Jiao, Yongjun Yu, Minying Zheng, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 2
Open Access | Times Cited: 11
Yuqi Jiao, Yongjun Yu, Minying Zheng, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 2
Open Access | Times Cited: 11
The complexity of immune evasion mechanisms throughout the metastatic cascade
Nicole M. Haynes, Thomas B Chadwick, Belinda S. Parker
Nature Immunology (2024) Vol. 25, Iss. 10, pp. 1793-1808
Closed Access | Times Cited: 11
Nicole M. Haynes, Thomas B Chadwick, Belinda S. Parker
Nature Immunology (2024) Vol. 25, Iss. 10, pp. 1793-1808
Closed Access | Times Cited: 11
Sulfonated Perylene as Three‐in‐One STING Agonist for Cancer Chemo‐Immunotherapy
Xue‐Jie Zhao, Rijie Zheng, Bianbian Zhang, et al.
Angewandte Chemie International Edition (2024) Vol. 63, Iss. 11
Closed Access | Times Cited: 10
Xue‐Jie Zhao, Rijie Zheng, Bianbian Zhang, et al.
Angewandte Chemie International Edition (2024) Vol. 63, Iss. 11
Closed Access | Times Cited: 10
cGAS-activated endothelial cell–T cell cross-talk initiates tertiary lymphoid structure formation
Ruibo Zhao, Jinghe Zhang, Jialu Ma, et al.
Science Immunology (2024) Vol. 9, Iss. 98
Closed Access | Times Cited: 10
Ruibo Zhao, Jinghe Zhang, Jialu Ma, et al.
Science Immunology (2024) Vol. 9, Iss. 98
Closed Access | Times Cited: 10